Results 251 to 260 of about 54,453 (265)

THE BATH ANKYLOSING SPONDYLITIS PATIENT GLOBAL SCORE (BAS-G)

Rheumatology, 1996
A Calin
exaly  

Evaluation of Tp-e interval and Tp-e/QT ratio in patients with ankylosing spondylitis

Modern Rheumatology, 2014
Mehmet Fatih Inci, Inci Mehmet Fatih
exaly  

Human medicines European public assessment report (EPAR): Hulio, adalimumab, Hidradenitis Suppurativa,Psoriasis,Crohn Disease,Uveitis,Arthritis, Rheumatoid,Colitis, Ulcerative,Spondylitis, Ankylosing,Arthritis, Psoriatic, Date of authorisation: 16/09/2018, Revision: 1, Status: Authorised

Case Medical Research, 2019
openaire   +1 more source

Human medicines European public assessment report (EPAR): Hulio, adalimumab, Hidradenitis Suppurativa,Psoriasis,Crohn Disease,Uveitis,Arthritis, Rheumatoid,Colitis, Ulcerative,Spondylitis, Ankylosing,Arthritis, Psoriatic, Date of authorisation: 16/09/2018, Revision: 2, Status: Authorised

Case Medical Research, 2019
openaire   +1 more source

Human medicines European public assessment report (EPAR): Cyltezo, adalimumab, Hidradenitis Suppurativa,Arthritis, Psoriatic,Psoriasis,Crohn Disease,Arthritis, Juvenile Rheumatoid,Uveitis,Arthritis, Rheumatoid,Colitis, Ulcerative,Spondylitis, Ankylosing, Date of authorisation: 10/11/2017, Revision: 2, Status: Withdrawn

Case Medical Research, 2019
openaire   +2 more sources

Human medicines European public assessment report (EPAR): Humira, adalimumab, Spondylitis, Ankylosing,Arthritis, Juvenile Rheumatoid,Uveitis,Colitis, Ulcerative,Psoriasis,Arthritis, Psoriatic,Crohn Disease,Arthritis, Rheumatoid, Date of authorisation: 08/09/2003, Revision: 74, Status: Authorised

Case Medical Research, 2019
openaire   +1 more source

Human medicines European public assessment report (EPAR): Imraldi, adalimumab, Hidradenitis Suppurativa,Psoriasis,Crohn Disease,Uveitis,Arthritis, Rheumatoid,Arthritis,Colitis, Ulcerative,Spondylitis, Ankylosing,Arthritis, Psoriatic, Date of authorisation: 24/08/2017, Revision: 8, Status: Authorised

Case Medical Research, 2019
openaire   +1 more source

Human medicines European public assessment report (EPAR): Kromeya, adalimumab, Arthritis, Rheumatoid,Arthritis, Juvenile Rheumatoid,Psoriasis,Arthritis, Psoriatic,Spondylitis, Ankylosing,Uveitis,Colitis, Ulcerative,Crohn Disease, Date of authorisation: 02/04/2019, Revision: 2, Status: Authorised

Case Medical Research, 2019
openaire   +1 more source

Human medicines European public assessment report (EPAR): Idacio, adalimumab, Arthritis, Rheumatoid,Arthritis, Juvenile Rheumatoid,Psoriasis,Arthritis, Psoriatic,Spondylitis, Ankylosing,Uveitis,Hidradenitis Suppurativa,Colitis, Ulcerative,Crohn Disease, Date of authorisation: 02/04/2019, Status: Authorised

Case Medical Research, 2019
openaire   +1 more source

Human medicines European public assessment report (EPAR): Imraldi, adalimumab, Hidradenitis Suppurativa,Psoriasis,Crohn Disease,Uveitis,Arthritis, Rheumatoid,Arthritis,Colitis, Ulcerative,Spondylitis, Ankylosing,Arthritis, Psoriatic, Date of authorisation: 24/08/2017, Revision: 10, Status: Authorised

Case Medical Research, 2019
openaire   +1 more source